Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.

[1]  J. Nakashima,et al.  Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. , 2010, The Journal of urology.

[2]  Sanjay G. Patel,et al.  Preoperative hydronephrosis predicts extravesical and node positive disease in patients undergoing cystectomy for bladder cancer. , 2010, The Journal of urology.

[3]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[4]  T. Guzzo,et al.  Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. , 2008, Urology.

[5]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[6]  H. Malik,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma , 2008, World Journal of Surgery.

[7]  Sung Hoon Kim,et al.  Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.

[8]  Shigemi Matsumoto,et al.  The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.

[9]  P. Carroll,et al.  Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. , 2007, The Journal of urology.

[10]  R. Kuefer,et al.  Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series. , 2007, European urology.

[11]  D. Bajorin,et al.  Defining optimal therapy for muscle invasive bladder cancer. , 2007, The Journal of urology.

[12]  M. Benson,et al.  Muscle-invasive urothelial carcinoma of the bladder. , 2007, Urology.

[13]  Y. Lotan,et al.  Precystectomy nomogram for prediction of advanced bladder cancer stage. , 2006, European urology.

[14]  J. Bartlett,et al.  The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder , 2006, British Journal of Cancer.

[15]  C. Dinney Therapy of invasive bladder cancer. , 2006, Urology.

[16]  E. Kikuchi,et al.  Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. , 2005, The Journal of urology.

[17]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.

[18]  C. Vale Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .

[19]  G. Hospers,et al.  Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.

[20]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[21]  P. Royston,et al.  Metastatic renal carcinoma comprehensive prognostic system , 2003, British Journal of Cancer.

[22]  R. Záhorec Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.

[23]  D. Bostwick,et al.  Predicting the survival of bladder carcinoma patients treated with radical cystectomy , 2000, Cancer.

[24]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[25]  T. Nishi,et al.  Autocrine Growth of Transitional Cell Carcinoma of the Bladder Induced by Granulocyte-Colony Stimulating Factor 1 , 2006 .

[26]  R. Dodge,et al.  Clinical variables which serve as predictors of cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate , 1994, Cancer.